Pfizer will be able to deliver 200 million COVID-19 vaccine doses by the end of May


Pfizer will be able to provide the United States with 200 million doses of the COVID-19 vaccine it developed alongside BioNTech by the end of May, CEO Albert Bourla said Tuesday, per Bloomberg. That's two months ahead of the previous July 31 deadline the company had set for itself.
The reason for the apparent fast-tracking is actually a Food and Drug Administration-approved label change, which went into effect Monday, allowing health care workers to extract an additional sixth dose from each vial, so production levels won't necessarily increase. Bourla also said the alteration means Pfizer will be able to deliver 120 million doses to the U.S. by the end of March, 20 million more than promised when the vaccine was initially granted emergency use.
As Bloomberg notes, the expedited timeline comes amid widespread concern about the slower-than-anticipated pace of the vaccine rollout in the U.S., so it's welcome news, though Bourla also suggested things will pick up in the coming weeks, either way. Read more at Bloomberg.
The Week
Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.

Sign up for The Week's Free Newsletters
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
A free daily email with the biggest news stories of the day – and the best features from TheWeek.com
Tim is a staff writer at The Week and has contributed to Bedford and Bowery and The New York Transatlantic. He is a graduate of Occidental College and NYU's journalism school. Tim enjoys writing about baseball, Europe, and extinct megafauna. He lives in New York City.
-
Marisa Silver’s 6 favorite books that capture a lifetime
Feature The author recommends works by John Williams, Ian McEwan, and more
-
Book reviews: ‘We the People: A History of the U.S. Constitution’ and ‘Will There Ever Be Another You’
Feature The many attempts to amend the U.S. Constitution and Patricia Lockwood’s struggle with long Covid
-
Philadelphia’s Calder Gardens
Feature A permanent new museum
-
FDA OKs generic abortion pill, riling the right
Speed Read The drug in question is a generic version of mifepristone, used to carry out two-thirds of US abortions
-
RFK Jr. vaccine panel advises restricting MMRV shot
Speed Read The committee voted to restrict access to a childhood vaccine against chickenpox
-
Texas declares end to measles outbreak
Speed Read The vaccine-preventable disease is still spreading in neighboring states, Mexico and Canada
-
RFK Jr. shuts down mRNA vaccine funding at agency
Speed Read The decision canceled or modified 22 projects, primarily for work on vaccines and therapeutics for respiratory viruses
-
Measles cases surge to 33-year high
Speed Read The infection was declared eliminated from the US in 2000 but has seen a resurgence amid vaccine hesitancy
-
Kennedy's vaccine panel signals skepticism, change
Speed Read RFK Jr.'s new vaccine advisory board intends to make changes to the decades-old US immunization system
-
Kennedy ousts entire CDC vaccine advisory panel
speed read Health Secretary RFK Jr. is a longtime anti-vaccine activist who has criticized the panel of experts
-
RFK Jr. scraps Covid shots for pregnant women, kids
Speed Read The Health Secretary announced a policy change without informing CDC officials